(NYSEMKT: AZTR) Azitra's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 16.65%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 33.72%.
Azitra's earnings in 2026 is -$11,814,265.On average, 4 Wall Street analysts forecast AZTR's earnings for 2026 to be -$2,890,350, with the lowest AZTR earnings forecast at -$4,284,519, and the highest AZTR earnings forecast at -$1,360,165. On average, 4 Wall Street analysts forecast AZTR's earnings for 2027 to be -$5,285,212, with the lowest AZTR earnings forecast at -$8,727,724, and the highest AZTR earnings forecast at -$1,530,185.
In 2027, AZTR is forecast to generate -$1,734,210 in earnings, with the lowest earnings forecast at -$2,062,917 and the highest earnings forecast at -$1,360,165.